Bloom Energy enters its July 30 earnings release having already delivered the worst of the news — a 34% monthly decline to $166.84 — and with the Street scrambling to reprice on the morning after a bruising session.
The analyst response to Tuesday's 11% drop was swift and unusually clustered. JP Morgan's Mark Strouse, who raised his target to $346 just eight days ago, reversed course on Wednesday and cut back to $314. UBS trimmed from $350 to $300. BMO Capital dropped its view from $279 to $227. The cuts share a common thread: firms are maintaining their ratings but pulling targets sharply lower, acknowledging that the stock has repriced faster than estimates. The consensus still leans constructive — all 13 analysts in the current sample hold ratings of Hold or better, with no Underperforms — and the mean target of $280 implies substantial recovery potential from current levels. Bernstein offered a small outlier move, nudging its Market Perform target up from $276 to $282, suggesting at least one house sees the selloff as having overshot.
Options traders have stuck with the contrarian call-heavy stance that has defined positioning for the past two weeks. The put/call ratio has eased to 1.10, running nearly 1.8 standard deviations below its 20-day average of 1.23 — unusual persistence in a stock down 26% on the week. Buyers are loading calls into a falling tape, not reaching for puts. The 52-week PCR low is 0.57, so positioning is not at a historical extreme, but the direction is unambiguous. The borrow market offers no counterweight to this view: availability remains extraordinarily loose at 4,842%, and the cost to borrow has dropped 21% on the week to just 0.31%. There is no lending-market tension, no short squeeze setup, and no sign the borrow is tightening around the earnings date.
Short interest is worth a brief note given the change in direction. After a dramatic covering wave — SI % of free float collapsed from above 12% in early July to a low around 7.5% — shorts have edged back in over the past week, rising roughly 5% to 7.9% of the float. That is a small reversal, not a rebuilding. The absolute level is still less than two-thirds of where it stood three weeks ago, and with availability above 4,800%, new shorts face no friction entering the name.
The fundamental story remains split. Bulls point to extraordinary EPS momentum — the 90-day and 12-month forward EPS revision scores rank in the 92nd and 100th percentiles respectively — alongside strong earnings surprise history (91st percentile) and growing on-site power demand. The one prior earnings print in this dataset delivered a 7% next-day gain. Bears counter that valuation remains stretched: the P/E has compressed sharply from the 30-day peak but still runs at 46.7x, P/B at 22.9x, and the EV/EBITDA factor score ranks at just the 1st percentile. Insider activity over the past 90 days adds a layer of caution — the Chief Commercial Officer, COO, Chief Legal Officer, and Chief Accounting Officer all sold shares in May and June, with director John Chambers liquidating $16.4 million at $297.69. These were routine dispersals at higher prices, not distress signals, but they set a backdrop of net insider selling into the peak.
The July 30 print is the next inflection point. With targets cut, positioning tilted toward calls, and short sellers modestly rebuilding from a low base, the market is not positioned for catastrophe — but the gap between where the stock is trading and where the Street's targets cluster makes the guidance commentary and any revision to the datacenter power demand outlook the deciding factor for the next leg.
See the live data behind this article on ORTEX.
Open BE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
